John Sundy
John Sundy , Independent directorAt a Glance
Date of birth
October 07, 1961
Nationality
American
First elected or appointed
April 2024
Term expires
General Meeting 2027
Education and Business Experience
John Sundy is currently Chief Medical Officer and Head of Research and Development at Seicmic Therapeutic, a machine learning immunology company and is Adjunct Professor of Medicine in the Division of Rheumatology and Immunology at Duke University School of Medicine. He was a tenured faculty member at Duke University before moving to the biotech industry in 2014. Between 2014 and 2021, he held several management positions including Senior Vice President at Gilead Sciences, and Chief Medical Officer at Pandion Therapeutics.
He is also a director of Neutrolis, Inc, and the Childhood Arthritis and Rheumatology Research Alliance, and serves on the Steering Committee of the NIH Immune Tolerance Network.
John Sundy obtained a B.S. in biology from Bucknell University and a M.D./Ph.D from Hahnemann University with a specialization in immunology, and completed clinical training in rheumatology and allergy/immunology at Duke.
Contact information
46, avenue de la Grande Armée - 75017 Paris (France)
Directorships & Appointments
Inside the Sanofi Group
Independent director
Member of the Scientific Committee
Outside the Sanofi Group
Neutrolis, Inc. : Director
Childhood Arthritis and Rheumatology Research Alliance (CARRA) : Director
Meet the Sanofi Board of Directors
Frédéric Oudéa
Chairman of the Board of Directors
